The Clinical Relevance of Compound Heterozygosity for the C282Y and H63D Substitutions in Hemochromatosis

Niederau, 1985, Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis, N Engl J Med, 313, 1256, 10.1056/NEJM198511143132004 Niederau, 1996, Long-term survival in patients with hereditary hemochromatosis, Gastroenterology, 110, 1107, 10.1053/gast.1996.v110.pm8613000 Bacon, 1999, Molecular medicine and hemochromatosis: at the crossroads, Gastroenterology, 116, 193, 10.1016/S0016-5085(99)70244-1 Olynyk, 1999, A population-based study of the clinical expression of the hemochromatosis gene, N Engl J Med, 341, 718, 10.1056/NEJM199909023411002 Feder, 1996, A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis, Nat Genet, 13, 399, 10.1038/ng0896-399 Gochee, 2002, A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation, Gastroenterology, 122, 646, 10.1016/S0016-5085(02)80116-0 Bacon, 1999, HFE genotype in patients with hemochromatosis and other liver diseases, Ann Intern Med, 130, 953, 10.7326/0003-4819-130-12-199906150-00002 Brissot, 1999, A genotypic study of 217 unrelated probands diagnosed as “genetic hemochromatosis” on “classical” phenotypic criteria, J Hepatol, 30, 588, 10.1016/S0168-8278(99)80188-3 Tavill, 2001, Diagnosis and management of hemochromatosis, Hepatology, 33, 1321, 10.1053/jhep.2001.24783 Beutler, 1997, The significance of the 187G (H63D) mutation in hemochromatosis, Am J Hum Genet, 61, 762, 10.1016/S0002-9297(07)64339-0 Crawford, 1998, Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation, Gastroenterology, 114, 1003, 10.1016/S0016-5085(98)70320-8 Phatak, 2002, Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients, Blood Cells Mol Dis, 29, 41, 10.1006/bcmd.2002.0536 Moirand, 1999, Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives, Gastroenterology, 116, 372, 10.1016/S0016-5085(99)70134-4 Beutler, 1996, Mutation analysis in hereditary hemochromatosis, Blood Cells Mol Dis, 22, 187, 10.1006/bcmd.1996.0027 Powell, 2006, Screening for hemochromatosis in asymptomatic subjects with or without a family history, Arch Intern Med, 166, 294, 10.1001/archinte.166.3.294 Leggett, 1990, Prevalence of haemochromatosis amongst asymptomatic Australians, Br J Haematol, 74, 525, 10.1111/j.1365-2141.1990.tb06345.x Fletcher, 2002, Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis, Gastroenterology, 122, 281, 10.1053/gast.2002.30992 Jazwinska, 1996, Haemochromatosis and HLA-H, Nat Genet, 14, 249, 10.1038/ng1196-249 Bassett, 1986, Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis, Hepatology, 6, 24, 10.1002/hep.1840060106 Leggett, 1990, Factors affecting the concentrations of ferritin in serum in a healthy Australian population, Clin Chem, 36, 1350, 10.1093/clinchem/36.7.1350 Searle, 1987 Scheuer, 1991, Classification of chronic viral hepatitis: a need for reassessment, J Hepatol, 13, 372, 10.1016/0168-8278(91)90084-O Adams, 2001, Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?, Am J Gastroenterol, 96, 567, 10.1111/j.1572-0241.2001.03472.x Adams, 2005, Hemochromatosis and iron-overload screening in a racially diverse population, N Engl J Med, 352, 1769, 10.1056/NEJMoa041534 Asberg, 2001, Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons, Scand J Gastroenterol, 36, 1108, 10.1080/003655201750422747 Schoniger-Hekele, 2002, Liver pathology in compound heterozygous patients for hemochromatosis mutations, Liver, 22, 295, 10.1034/j.1600-0676.2002.01597.x Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604 Moirand, 2002, HFE based re-evaluation of heterozygous hemochromatosis, Am J Med Genet, 111, 356, 10.1002/ajmg.10547 Mendler, 1999, Insulin resistance-associated hepatic iron overload, Gastroenterology, 117, 1155, 10.1016/S0016-5085(99)70401-4 Beutler, 2002, Penetrance of 845G - A (C282Y) HFE hereditary haemochromatosis mutation in the USA, Lancet, 359, 211, 10.1016/S0140-6736(02)07447-0 Lim, 2004, Hepatic iron loading in patients with compound heterozygous HFE mutations, Liver Int, 24, 631, 10.1111/j.1478-3231.2004.0953.x George, 1998, Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis, Gastroenterology, 114, 311, 10.1016/S0016-5085(98)70482-2 Bonkovsky, 1999, Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis, J Hepatol, 31, 421, 10.1016/S0168-8278(99)80032-4 Tung, 2003, Hepatitis C, iron status, and disease severity: relationship with HFE mutations, Gastroenterology, 124, 318, 10.1053/gast.2003.50046 Sullivan, 2001, Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease, Eur J Clin Invest, 31, 375, 10.1046/j.1365-2362.2001.00830.x Nelson, 2001, Iron and colorectal cancer risk: human studies, Nutr Rev, 59, 140, 10.1111/j.1753-4887.2001.tb07002.x Nelson, 1995, Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis, Cancer, 76, 875, 10.1002/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0.CO;2-Q McCune, 2006, Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients, Gut, 55, 554, 10.1136/gut.2005.070342